Clinical Trials for Acute Myeloid Leukemia (AML)
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Acute Myeloid Leukemia (AML)
Acute myeloid leukemia (AML) is a cancerous, proliferation of the myeloblast, a type of white blood cell, localized in bone marrow.
acute myeloid leukemia aml acute-myeloid-leukemia acute-myelogenous-leukemia